Kratz JD - Search Results

1

Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current Practice.

Patel MA, Kratz JD, Lubner SJ, Loconte NK, Uboha NV. Patel MA, et al. Among authors: kratz jd. J Clin Oncol. 2022 Aug 20;40(24):2751-2762. doi: 10.1200/JCO.21.02500. Epub 2022 Jul 15. J Clin Oncol. 2022. PMID: 35839430 Free PMC article. Review.

2

The Multidisciplinary Management of Colorectal Cancer: Present and Future Paradigms.

Sievers CK, Kratz JD, Zurbriggen LD, LoConte NK, Lubner SJ, Uboha N, Mulkerin D, Matkowskyj KA, Deming DA. Sievers CK, et al. Among authors: kratz jd. Clin Colon Rectal Surg. 2016 Sep;29(3):232-8. doi: 10.1055/s-0036-1584292. Clin Colon Rectal Surg. 2016. PMID: 27582648 Free PMC article. Review.

3

Metastatic Bulk Independently Predicts Outcomes for EGFR Precision Targeting in Colorectal Cancer.

Kratz JD, Uboha NV, Lubner SJ, Mulkerin DL, Clipson L, Yi Y, Yu M, Matkowskyj KA, LoConte NK, Deming DA. Kratz JD, et al. J Natl Compr Canc Netw. 2018 Dec;16(12):1442-1450. doi: 10.6004/jnccn.2018.7074. J Natl Compr Canc Netw. 2018. PMID: 30545991

4

Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases.

Kratz JD, LoConte NK. Kratz JD, et al. Ann Surg Oncol. 2020 Oct;27(11):4075-4078. doi: 10.1245/s10434-020-08629-w. Epub 2020 May 22. Ann Surg Oncol. 2020. PMID: 32444912 No abstract available.

5

Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer.

Hossan MS, Lin ES, Riedl E, Stram A, Mehlhaff E, Koeppel L, Warner J, Uko I, Mankowski Gettle L, Lubner S, McGregor SM, Zhang W, Murphy W, Kratz JD. Hossan MS, et al. Among authors: kratz jd. Bioengineering (Basel). 2023 Jan 10;10(1):91. doi: 10.3390/bioengineering10010091. Bioengineering (Basel). 2023. PMID: 36671664 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 37785155

7

Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer.

Kratz J, Burkard M, O'Meara T, Pusztai L, Veitch Z, Bedard PL. Kratz J, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:56-64. doi: 10.1200/EDBK_200731. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231387 Free article. Review.

8

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers.

Fricke SL, Payne SN, Favreau PF, Kratz JD, Pasch CA, Foley TM, Yueh AE, Van De Hey DR, Depke MG, Korkos DP, Sha GC, DeStefanis RA, Clipson L, Burkard ME, Lemmon KK, Parsons BM, Kenny PA, Matkowskyj KA, Newton MA, Skala MC, Deming DA. Fricke SL, et al. Among authors: kratz jd. Mol Cancer Ther. 2019 Feb;18(2):346-355. doi: 10.1158/1535-7163.MCT-18-0510. Epub 2018 Nov 13. Mol Cancer Ther. 2019. PMID: 30425131 Free PMC article.

9

Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity.

DeStefanis RA, Kratz JD, Olson AM, Sunil A, DeZeeuw AK, Gillette AA, Sha GC, Johnson KA, Pasch CA, Clipson L, Skala MC, Deming DA. DeStefanis RA, et al. Among authors: kratz jd. Sci Rep. 2022 Mar 25;12(1):5205. doi: 10.1038/s41598-022-08937-z. Sci Rep. 2022. PMID: 35338174 Free PMC article.

10

Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review.

DeStefanis RA, Kratz JD, Emmerich PB, Deming DA. DeStefanis RA, et al. Among authors: kratz jd. Curr Colorectal Cancer Rep. 2019 Apr;15(2):61-69. doi: 10.1007/s11888-019-00430-6. Epub 2019 Mar 20. Curr Colorectal Cancer Rep. 2019. PMID: 31130830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page